Coxistac 12% Granular 120 g (Salinomycin Sodium DRUG PREMIX) 120 G

COXISTAC 12% Granular is a veterinary drug premix containing Salinomycin Sodium, used for managing coccidiosis in poultry. This 25kg pack is designed for oral administration to support animal health.

Strength

120 G

Pack Size

25KG

Manufacturer / TM Owner

PHIBRO ANIMAL HEALTH CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

COXISTAC 12% Granular is primarily used for the prevention and treatment of coccidiosis in poultry. Coccidiosis is a parasitic disease that affects the intestinal tract of birds, causing symptoms like diarrhea and weight loss. This drug premix helps in controlling the infection and promoting overall health in poultry. Farmers often use Salinomycin Sodium to maintain flock health and productivity.

Side Effects

When administered as directed, COXISTAC 12% Granular helps in reducing the severity of coccidiosis symptoms in poultry. It works by targeting the parasites responsible for the infection, thereby improving the overall health and performance of the birds. Regular use can help in maintaining the well-being of the flock.

Precautions & Warnings

COXISTAC 12% Granular should be handled with care, ensuring it is stored in a cool, dry place away from direct sunlight. It is important to follow the manufacturer's guidelines for administration to avoid any potential adverse effects. Always consult with a veterinarian before use to ensure it is suitable for your specific flock's needs.

Avoid Interactions

COXISTAC 12% Granular may interact with other medications or supplements. It is advisable to inform your veterinarian about any other treatments your poultry is receiving to avoid potential interactions. Additionally, avoid mixing with other feed additives unless specifically instructed by a professional.

Frequently Asked Questions

COXISTAC 12% Granular is used for the prevention and treatment of coccidiosis in poultry.

COXISTAC 12% Granular is designed for oral administration in poultry feed. Follow the manufacturer's guidelines for proper usage.

COXISTAC 12% Granular helps in reducing the severity of coccidiosis symptoms and improves the overall health and performance of poultry.

COXISTAC 12% Granular should be stored in a cool, dry place and administered as directed. Consult a veterinarian before use.

COXISTAC 12% Granular may interact with other medications. Consult a veterinarian before combining with other treatments.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.